Dr. Priya Deshmukh - Senior Editor, Health 
In a significant development for public health, the U.S. Food and Drug Administration (FDA) has expanded the approved age indication for GSK’s Arexvy (Respiratory Syncytial Virus vaccine, adjuvanted) to include adults aged 18 to 49 years who are at increased risk for lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV). Previously, Arexvy … Read more
The fight against Lyme disease and other tick-borne illnesses is gaining momentum in Quebec, with a new research project set to evaluate the effectiveness of preventative measures in high-risk areas. Researchers from Cégep de Saint-Hyacinthe, Université de Montréal, and Université de Sherbrooke are recruiting over 200 households in the Estrie and Montérégie regions to participate … Read more
AI chatbots are becoming increasingly popular among teenagers seeking nutritional advice, but a recent study raises concerns about the adequacy and safety of the recommendations they provide. A study published in Frontiers in Nutrition highlights that these tools often suggest meal plans that are unbalanced and potentially harmful, particularly for adolescents who are still in … Read more
Managing anesthesia for patients with existing cardiovascular conditions presents unique challenges for medical teams. A recent case report highlights the successful anesthetic management of a laparoscopic surgery performed on a patient with an uncomplicated Type B aortic dissection. This case underscores the importance of careful pre-operative assessment, meticulous intraoperative monitoring, and a collaborative approach to … Read more